Impact of chronic antithrombotic therapy on hospital course of patients with acute myocardial infarction

Clinical Cardiology

Volumn 32, Issue 12, 2009, Pages 718-723

  Bauer, Timm ^a   Gitt, Anselm ^a,b   Zahn, Ralf ^a   Jünger, Claus ^b   Koeth, Oliver ^a   Towae, Frank ^a   Bestehorn, Kurt ^c   Senges, Jochen ^b   Zeymer, Uwe ^a,b  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Merck Sharp and Dohme   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; CREATINE KINASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; AGED; AGING; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEART INFARCTION SIZE; HEART LEFT BUNDLE BRANCH BLOCK; HEART MUSCLE REPERFUSION; HEART REINFARCTION; HOSPITALIZATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; SEX DIFFERENCE; ST SEGMENT ELEVATION; STROKE; TREATMENT OUTCOME;

AGE FACTORS; AGED; ANTICOAGULANTS; ASPIRIN; BUNDLE-BRANCH BLOCK; COUMARINS; DIABETES MELLITUS; FEMALE; GERMANY; HEMORRHAGE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; REGISTRIES; RENAL INSUFFICIENCY; RISK FACTORS; SEX FACTORS; SHOCK, CARDIOGENIC; STROKE;

EID: 74849121790     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20666     Document Type: Article

References (17)

1. Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis (ASPECT) Research Group. Effect of long-term oral anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infarction. Lancet. 1994;343:499-503.
2. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardila infarction, and stroke in high risk patients. BMJ. 2002;324:71-86.
3. Elwood PC, Sweetnam PM. Aspirin and secondary mortality after myocardial infarction. Lancet. 1979;2:499-503.
4. Alexander JH, Harrington RA, Tuttle RH, et al. Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT Investigators. Platelet IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy. Am J Cardiol. 1999;83:1147-1151.
5. Cohen M, Adams PC, McBride R, et al. Prospective comparison of patient characteristics and outcome of non-prior aspirin users versus aspirin users with unstable angina or non-Q-wave myocardial infarction treated with combination antithrombotic therapy. J Thromb Thrombolysis. 1997;4:275-280.
6. Lancaster GI, Lancaster CJ, Radley D, et al. Prior aspirin use in unstable angina predisposes to higher risk: the aspirin paradox. Int J Cardiol. 2001;80:201-207.
7. Santopinto J, Gurfinkel EP, Torres V, et al. Prior aspirin users with acute non-ST-elevation coronary syndromes are at increased risk of cardiac events and benefit from enoxaparin. Am Heart J. 2001;141:566-572.
8. Garcia-Dorado D, Theroux P, Tornos P, et al. Previous aspirin use may attentuate the severity of the manifestation of acute ischemic syndromes. Circulation. 1995;92:1743-1748.
9. Portnay EL, Foody JM, Rathore SS, et al. Prior aspirin use and outcomes in elderly patients hospitalized with acute myocardial infarction. J Am Coll Cardiol. 2005;46:967-974.
10. Spencer FA, Santopinto JJ, Gore JM, et al. Impact of aspirin on presentation and hospital outcomes in patients with acute coronary syndromes (The Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol. 2002;90:1056-1061.
11. Oudot A, Steg PG, Danchin N, et al. Impact of chronic oral anticoagulation on management and outcomes of patients with acute myocardial infarction: data from the RICO survey. Heart. 2006;92: 1077-1083.
12. Wang TY, Chen AY, Petersen ED, et al. Impact of home warfarin use on treatment patterns and bleeding complications for patients with non-ST-segment elevation acute coronary syndromes: observations from the CRUSADE quality improvement initiative. Eur Heart J. 2008;29:1103-1109.
13. Friesinger GC, Smith EF. Old age, left bundle branch block and acute myocardial infarction: a vexing and lethal combination. J Am Coll Cardiol. 2000;3:713-716.
14. Stenestrand U, Tabrizi F, Lindbäck J, et al. Comorbidity and myocardial dysfunction are the main explanations for the higher 1-year mortality in acute myocardial infarction with left bundle-branch block. Circulation. 2004;110:1896-1902.
15. Rosengren A, Wallentin L, Simoons M, et al. Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey. Eur Heart J. 2006;27: 789-795.
16. Yan RT, Yan AT, Tan M, et al; for the Canadian Acute Coronary Syndromes Registry Investigators. Age-related differences in the management and outcome of patients with acute coronary syndromes. Am Heart J. 2006;151:352-359.
17. De Wood MA, Spores J, Notske R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med. 1980;303:897-902.